Liver tumors as the fourth leading cause of death from cancer in the world, the death rate is increasing year by year. Liver cancer has long been a global problem. The World Health Organization projects that more than one million people will die of liver cancer by 2030. At present, surgery, which includes liver surgery and transplantation, is still the main treatment for liver cancer. Additionally, the use of surgical robots in liver surgery is growing almost daily. However, there are still many unknown areas in the development of liver surgery. The improvement of new surgical concepts and standards, surgical skills, the study of intraoperative and postoperative complications, and the development of clinical prediction models remain to be further studied. This topic aims to discuss the novel technical findings, improvements, scoring criteria, prediction models, and clinical biomarkers for surgery in liver tumors.
We welcome Original Research, Review, and Mini Review in the subtopics, including but not limited to:
1. Prognostic relationship between novel clinical markers and prediction/prognosis of liver tumors.
2. Surgical skill improvement for liver tumors.
3. Various surgical presentations of liver surgery.
4. Construction of clinical prediction model.
5. Association of clinically relevant indicators with the prognosis of liver cancer.
6. Comprehensive gene analysis.
7. Development of graft versus host disease after liver transplantation.
8. Combination with other cutting-edge therapeutic modalities.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Liver tumors as the fourth leading cause of death from cancer in the world, the death rate is increasing year by year. Liver cancer has long been a global problem. The World Health Organization projects that more than one million people will die of liver cancer by 2030. At present, surgery, which includes liver surgery and transplantation, is still the main treatment for liver cancer. Additionally, the use of surgical robots in liver surgery is growing almost daily. However, there are still many unknown areas in the development of liver surgery. The improvement of new surgical concepts and standards, surgical skills, the study of intraoperative and postoperative complications, and the development of clinical prediction models remain to be further studied. This topic aims to discuss the novel technical findings, improvements, scoring criteria, prediction models, and clinical biomarkers for surgery in liver tumors.
We welcome Original Research, Review, and Mini Review in the subtopics, including but not limited to:
1. Prognostic relationship between novel clinical markers and prediction/prognosis of liver tumors.
2. Surgical skill improvement for liver tumors.
3. Various surgical presentations of liver surgery.
4. Construction of clinical prediction model.
5. Association of clinically relevant indicators with the prognosis of liver cancer.
6. Comprehensive gene analysis.
7. Development of graft versus host disease after liver transplantation.
8. Combination with other cutting-edge therapeutic modalities.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
